Author:
Gauci Marie-Léa,Jachiet Marie,Gottlieb Jeremy,Madeleine-Chambrin Isabelle,Rybojad Michel,Bagot Martine,Bouaziz Jean-David
Reference8 articles.
1. Epidemiologic, Clinicopathologic, Diagnostic, and Management Challenges of Pityriasis Rubra Pilaris: A Case Series of 100 Patients;Ross;JAMA Dermatol,2016
2. Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial;McInnes;Lancet Lond Engl,2015
3. A systematic review of the literature on the treatment of pityriasis rubra pilaris type 1 with TNF-antagonists;Petrof;J Eur Acad Dermatol Venereol,2013
4. Treatment of Refractory Pityriasis Rubra Pilaris With Novel Phosphodiesterase 4 (PDE4) Inhibitor Apremilast;Krase;JAMA Dermatol,2016
5. Treatment of pityriasis rubra pilaris with ustekinumab;Wohlrab;Br J Dermatol,2010
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献